The neurotoxicity of statin drugs are back in the news.
Following on the heels of the FDA decision earlier this year to require statin drugs manufacturers to add"memory loss" as a side effect of this chemical class, a new study in published in the Journal of Diabetes reveals a clear association between statin use and peripheral neuropathy in a US population 40 years of age and older.
The study found "The prevalence of peripheral neuropathy was significantly higher among those who used statins compared to those who did not (23.5% vs. 13.5%; p < 0.01)," which is a 75% increase in relative risk.
Case reports of statin-induced peripheral neuropathy have existed in the medical literature for over 15 years.
Now, larger human studies are confirming that statin drugs do damage to the peripheral nerves...